The current financial score of Clover Health Investments Corp is 8.77. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 743.17M, representing a year-over-year increase of 55.60%, while its net profit experienced a year-over-year increase of 364.71%.
The current valuation score of Clover Health Investments Corp is 8.62. Its current P/E ratio is -40.47, which is -97.45% below the recent high of -1.03 and -82.96% above the recent low of -74.04.
The current earnings forecast score of Clover Health Investments Corp is 6.50. The average price target is 4.65, with a high of 6.00 and a low of 1.75.
The current price momentum score of Clover Health Investments Corp is 4.81. Currently, the stock price is trading between the resistance level at 5.14 and the support level at 3.99, making it suitable for range-bound swing trading.
The current institutional shareholding score of Clover Health Investments Corp is 3.00. The latest institutional shareholding proportion is 29.56%, representing a quarter-over-quarter decrease of 19.79%. The largest institutional shareholder is James Simons, holding a total of 2.81M shares, representing 0.02% of shares outstanding, with 66.18% decrease in holdings.
The current risk assessment score of Clover Health Investments Corp is 4.09. The company's beta value is 2.55. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.